Return on investment stories

Addressing the 4^th GAVI Partners' Forum, Andrew Witty, GlaxoSmithKline CEO, pays tribute to the catalytic role of the Advanced Market Commitment (AMC).

It would be a cruel irony if an injection to prevent one disease merely inflicted another. Yet, without safe injection practices, expanding vaccine coverage in the age of highly transmissible diseases such as HIV/AIDS, runs a very real risk of spreading infection.

Despite the advantages of the 5-in-1 pentavalent vaccine, political will to drive widespread roll-out was lacking -- until GAVI support played a key role in changing market conditions.